DIN 02322854 — NPLATE 375 MCG
NPLATE is a powder for solution of Romiplostim marketed by AMGEN CANADA INC. The full Romiplostim monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02322854
- Brand name
- NPLATE
- Active ingredient
- Romiplostim
- Strength
- 375 MCG
- Dosage form
- POWDER FOR SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Thrombopoietin (TPO) receptor agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Romiplostim products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02322862 | NPLATE | 625 MCG | POWDER FOR SOLUTION | AMGEN CANADA INC | MARKETED |